NUFLAM

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
11-01-2021

有効成分:

glucosamine sulfate potassium chloride, Quantity: 667 mg (Equivalent: glucosamine sulfate, Qty 500 mg; Equivalent: potassium chloride, Qty 167 mg); shark chondroitin sulfate, Quantity: 278 mg (Equivalent: chondroitin sulfate, Qty 250 mg)

から入手可能:

Zifam Pinnacle Pty Ltd

医薬品形態:

Capsule, hard

構図:

Excipient Ingredients: Gelatin; calcium hydrogen phosphate dihydrate; sodium lauryl sulfate; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; purified water; titanium dioxide; iron oxide yellow; quinoline yellow

投与経路:

Oral

適応症:

Maintain/support general health and wellbeing ; Decrease/reduce/relieve mild joint aches and pains ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Helps maintain/supports healthy joint cartilage growth/development/production ; Maintain/support joint health ; Maintain/support joint mobility/flexibility

製品概要:

Visual Identification: ; Container Type: Multiple containers

認証ステータス:

Listed

承認日:

2020-12-24

ドキュメントの履歴を表示する